Prof. Dr. Meltem AYLI

1. Efficacy and Safety of Subcutaneous Efgartigimod PH20 in Adults With Primary Immune Thrombocytopenia (ADVANCE SC): A Multicenter, Randomized, Double-Blinded, Placebo-Controlled, Phase 3 Trial

Broome C. M., Miyakawa Y., McDonald V., Al-Samkari H., Khelif A., Cataland S. R., et al.

American Journal of Hematology , cilt.101, sa.7, ss.1494-1506, 2026 (SCI-Expanded, Scopus)

2. Real-world data on the use of asciminib in chronic-phase chronic myeloid leukemia after two or more prior tyrosine kinase inhibitors: Results of the Turkish managed access program along with a literature review

ÖZMEN İBİŞ D., Kürekçi D. D., ÖZKOCAMAN V., Altındağ Avcı B., Bozer D. S., Kasar M., et al.

Leukemia Research , cilt.166, 2026 (SCI-Expanded, Scopus)

3. From a Long-Standing Yellowish Plaque to a Diagnosis of a Rare Disorder: A Case of Erdheim–Chester Disease Treated With Vemurafenib

Yilmaz B., AKOĞLU G., Sayin S., KUZU I., Kivrak H., AYLI M.

American Journal of Medical Genetics, Part A , cilt.200, sa.5, ss.1117-1120, 2026 (SCI-Expanded, Scopus)

4. The Prognostic Significance of Sarcopenia Assessed by the Psoas Muscle Index in Multiple Myeloma Patients

Kilic Gunes E., Kilic K. K., AYLI M.

Indian Journal of Hematology and Blood Transfusion , cilt.42, sa.1, ss.73-81, 2026 (SCI-Expanded, Scopus)

5. Treatment Outcomes of Elderly Patients with Mantle Cell Lymphoma: A Multi-center Real-World Data

Kilic Gunes E., YAVAŞOĞLU F., Kucukyurt S., Aykas F., YİĞİT KAYA S., YILMAZ İ., et al.

Indian Journal of Hematology and Blood Transfusion , cilt.42, sa.1, ss.82-92, 2026 (SCI-Expanded, Scopus)

6. Metabolomic Profiling Reveals Distinct Signatures in Primary and Secondary Polycythemia

YILDIRIM M., Erdoğdu B., Sayın S., KAPLAN O., Koç E., Karadeniz M., et al.

Metabolites , cilt.15, sa.9, 2025 (SCI-Expanded, Scopus)

7. Metabolomic Profiling and Bioanalysis of Chronic Myeloid Leukemia: Identifying Biomarkers for Treatment Response and Disease Monitoring

Sayın S., YILDIRIM M., Erdoğdu B., KAPLAN O., Koç E., Bulduk T., et al.

Metabolites , cilt.15, sa.6, 2025 (SCI-Expanded, Scopus)

8. Therapeutic apheresis treatment in rheumatic diseases: Insights from a single-center experience

Çimen Güneş E., TEKGÖZ E., Çolak S., Sayın S., ŞİRİN H., AYLI M., et al.

Therapeutic Apheresis and Dialysis , cilt.29, sa.1, ss.123-130, 2025 (SCI-Expanded, Scopus)

9. The effect of bone marrow reticulin fibrosis degree at diagnosis on the success of intensive and reduced Intensity Induction therapy in de novo AML patients: retrospective single-center study

YILDIRIM M., Sayın S., ÇELİK E., Erdoğdu B., Özen K., AYLI M.

Hematology in Clinical Practice , cilt.16, ss.52-61, 2025 (Scopus)

10. Clinical characteristics and outcomes in Epstein–Barr virus-positive diffuse large B-cell lymphoma: a multicenter retrospective study

Kiliç Güneş E., AFACAN ÖZTÜRK H. B., Kiriktir E., Dikyar A., Uğur B., GÜNEŞ A. K., et al.

Turkish Journal of Medical Sciences , cilt.55, sa.5, ss.1113-1121, 2025 (SCI-Expanded, Scopus, TRDizin)

11. Clinical Outcomes and Prognostic Factors in AML with Hyperleukocytosis: A Multicenter Real-World Study

Kilic Gunes E., Savas E. M., Erdogdu B., Gorduk U., Gul D., AFACAN ÖZTÜRK H. B., et al.

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , cilt.35, sa.3, ss.212-220, 2025 (SCI-Expanded, Scopus, TRDizin)

12. Apheresis product total CD34+ cell count prediction at peripheral stem cell collection via a formula: A multicenter study

YILDIRIM M., Sayin S., Ertas Z., Ayyildiz E., Aksoyoglu I., Avcu F., et al.

Transplant Immunology , cilt.86, 2024 (SCI-Expanded, Scopus)

13. Eltrombopag treatment in thrombocytopenia following hematopoietic stem cell transplantation: A multicenter real-world experience

Kilic Gunes E., YİĞİT KAYA S., YAMAN F., Yeniay M. K., Vural K., Comert M., et al.

Leukemia Research , cilt.140, 2024 (SCI-Expanded, Scopus)

14. Comparison of Cyclophosphamide-Based Graft Versus Host Disease Prophylaxis after “Allogeneic Stem Cell Transplantation from 9/10 HLA Matched Unrelated Donor’’ with Standard Graft Versus Host Disease Prophylaxis after “10/10 HLA Matched Relative Donor’’ Transplant

YILDIRIM M., Sayın S., Cömert M., Yılmaz E. Ş., Avcu F., Ural A. U., et al.

International Journal of Hematology-Oncology and Stem Cell Research , cilt.18, sa.3, ss.227-239, 2024 (Scopus)

15. Management of Primary Immune Thrombocytopenia: Turkish Modified Delphi-Based Consensus Statement for Special Considerations Primer İmmün Trombositopeni Yönetimi: Özel Durumlar için Düzenlenmiş Türkiye Delphi Temelli Konsensus Bildirisi

ÜMİT E. G., DEMİR A. M., AR M. C., Ayer M., AYLI M., KARAKUŞ V., et al.

Turkish Journal of Hematology , cilt.41, sa.3, ss.141-145, 2024 (SCI-Expanded, Scopus, TRDizin)

16. Management of Adult Primary Immune Thrombocytopenia: Delphi-Based Consensus Recommendations Erişkin Primer İmmün Trombositopeni Yönetimi: Delphi-Temelli Uzlaşı Önerileri

DEMİR A. M., ÜMİT E. G., AR M. C., Ayer M., AYLI M., KARAKUŞ V., et al.

Turkish Journal of Hematology , cilt.41, sa.2, ss.97-104, 2024 (SCI-Expanded, Scopus, TRDizin)

17. Survival Outcomes of Patients with Primary Plasma Cell Leukemia in the Era of Proteasome Inhibitors and Immunomodulatory Agents: A Real-Life Multicenter Analysis Proteazom İnhibitörleri ve İmmünomodülatör Ajanlar Çağında Primer Plazma Hücreli Lösemili Hastaların Sağkalım Sonuçları: Gerçek Yaşam Verilerinden Çok Merkezli Bir Analiz

ATAŞ Ü., SALİM O., ILTAR U., YÜCEL O. K., Eroğlu A. H. K., Aslan V., et al.

Turkish Journal of Hematology , cilt.41, sa.4, ss.225-235, 2024 (SCI-Expanded, Scopus, TRDizin)

18. Risk Factors and Prognosis of Extramedullary Disease in Newly-Diagnosed Multiple Myeloma Patients

Kilic Gunes E., Bulduk T., Dumludag B., Zengin H., YILDIRIM M., Comert M., et al.

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , cilt.34, sa.4, ss.175-183, 2024 (SCI-Expanded, Scopus, TRDizin)

19. Comparison of Infectious Complications in Patients Receiving High-Dose Cyclophosphamide as GvHD Prophylaxis After Transplantation From A 9/10 HLA-Matched Unrelated Donor with Standard GvHD Prophylaxis After Transplant From A Fully Matched Related Donor

Sayın S., YILDIRIM M., Cömert M., Uğur B., Yılmaz E. Ş., Avcu F., et al.

Mediterranean Journal of Hematology and Infectious Diseases , cilt.16, sa.1, 2024 (SCI-Expanded, Scopus)

20. Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial

McDonald V., Miyakawa Y., Carpenedo M., Kuter D. J., Al-Samkari H., Bussel J. B., et al.

The Lancet , cilt.402, sa.10413, ss.1648-1659, 2023 (SCI-Expanded, Scopus)

21. Evaluation of Second Primary Cancer Risk Among Chronic Lymphocytic Leukemia Patients: Multicenter Study

Sayin S., Kiliacslan E., YILDIRIM M., AFACAN ÖZTÜRK H. B., Safak Yilmaz E., ALBAYRAK M., et al.

Asian Pacific journal of cancer prevention : APJCP , cilt.24, sa.6, ss.1971-1977, 2023 (Scopus)

22. Comparison of maintenance regimens in Acute Promyelocytic Leukemia patients

Kilic Gunes E., ÖZKURT Z. N., Yildiz S., Ozet G., CERAN F., ALBAYRAK M., et al.

Leukemia Research , cilt.128, 2023 (SCI-Expanded, Scopus)

23. Treatment options in primary mediastinal B cell lymphoma patients, retrospective multicentric analysis; a Turkish oncology group study

Acar R., PAYDAŞ S., YILDIRIM M., Kiliçarslan E., ŞAHİN U., DOĞAN A. A., et al.

Journal of Cancer Research and Therapeutics , cilt.19, sa.8, 2023 (SCI-Expanded, Scopus)

24. The Effect of Platelet and Mean Platelet Volume Levels on Standard-dose Methylprednisolone Treatment Response in Primary Immune Thrombocytopenia Primer İmmün Trombositopenide Trombosit ve Ortalama Trombosit Hacmi Düzeylerinin Standart Doz Metilprednizolon Tedavi Yanıtına Etkisi

Kilicaslan E., YILDIRIM M., Sayin S., ÇEVİK E., AYLI M., KAPTAN M. K.

Medeniyet Medical Journal , cilt.38, sa.1, ss.63-69, 2023 (Scopus, TRDizin)

25. CD5 as a prognostic marker in patients with diffuse large B-cell lymphoma: a multicenter study

DEMİRCİ U., KIRKIZLAR H. O., ÜMİT E. G., GÜRSOY V., PINAR İ. E., ÖZKALEMKAŞ F., et al.

Journal of Hematopathology , cilt.15, sa.4, ss.203-213, 2022 (SCI-Expanded, Scopus)

26. Brentuximab vedotin consolidation therapy after autologous stem-cell transplantation in patients with high-risk Hodgkin lymphoma: Multicenter retrospective study

Akay O. M., Ozbalak M., Pehlivan M., Yildiz B., UZAY A., YİĞENOĞLU T. N., et al.

Hematological Oncology , cilt.39, sa.4, ss.498-505, 2021 (SCI-Expanded, Scopus)

27. A case of psoriasis successfully treated by extracorporeal photopheresis during COVID-19 pandemic

Esme P., Coban S. N., Ugur B., AYLI M., ÇALIŞKAN E.

Transfusion and Apheresis Science , cilt.60, sa.5, 2021 (SCI-Expanded, Scopus)

28. Conditioning Regimens for Relapsed/Refractory Lymphoma Patients Undergoing Autologous Stem Cell Transplantation: BEAM Versus High Dose ICE

GÜNEŞ A. K., DAĞDAŞ S., CERAN F., Ucar M. A., Falay M., Sunu C., et al.

Indian Journal of Hematology and Blood Transfusion , cilt.37, sa.1, ss.82-89, 2021 (SCI-Expanded, Scopus)

29. Prognostic Factors in Patients with Low-Grade Nonhodgkin Lymphoma

Cömert P., Yıldız A., YILDIRIM M., AFACAN ÖZTÜRK H. B., Pala Ç., ALBAYRAK M., et al.

Indian Journal of Hematology and Blood Transfusion , cilt.36, sa.1, ss.78-83, 2020 (SCI-Expanded, Scopus)

30. Gonadotoxic effects of nilotinib in chronic myeloid leukemia treatment dose in a mouse model Kronik Miyeloid Lösemi tedavi dozunda nilotinib’in gonadotoksik etkilerinin fare modelinde gösterilmesi

CENGİZ SEVAL G., Özkavukçu S., SEVAL M. M., AYLI M.

Turkish Journal of Hematology , cilt.34, sa.2, ss.137-142, 2017 (SCI-Expanded, Scopus, TRDizin)

31. Xanthelasma palpebrarum: A new side effect of nilotinib

Sayin I., AYLI M., Oguz A. K., CENGİZ SEVAL G.

BMJ Case Reports , cilt.2016, 2016 (Scopus)

32. CD38 expression and variation as a prognostic factor chronic lymphocytic leukemia

Falay M., CERAN F., GÜNEŞ A. K., DAĞDAŞ S., AYLI M., Ozet G.

Clinical Laboratory , cilt.62, sa.7, ss.1287-1293, 2016 (SCI-Expanded, Scopus)

33. Ruxolitinib treatment in a patient with primary myelofibrosis resistant to conventional therapies and splenectomy: A case report Konvansiyonel tedavilere ve splenektomiye refrakter primer myelofibrozisli olguda ruxolitinib deneyimi

AYLI M., ÖZCAN M., CENGİZ SEVAL G.

Turkish Journal of Hematology , cilt.32, sa.2, ss.180-183, 2015 (SCI-Expanded, Scopus, TRDizin)

34. The evaluation of IMA as a cardiac ischemia marker in the cases of hypohemoglobinemia and hypoxemia due to blood loss Kan kaybi{dotless}na baǧli{dotless} hemoglobin düşüklüǧü ve hipoksemi durumunda kardiak iskemi belirteci olarak İMA

Şeker R., Oǧuz A. K., Özdemir S., Demirtaş S., AYLI M., Mergen K.

Turkish Journal of Biochemistry , cilt.39, sa.2, ss.221-225, 2014 (SCI-Expanded, Scopus, TRDizin)

35. Acupuncture for neuropathic pain due to bortezomib in a patient with multiple myeloma.

Mandiroǧlu S., ÇEVİK C., AYLI M.

Acupuncture in medicine : journal of the British Medical Acupuncture Society , cilt.32, sa.2, ss.194-196, 2014 (SCI-Expanded, Scopus)

36. Blood donors and factors impacting the blood donation decision: Motives for donating blood in Turkish sample

Karacan E., CENGİZ SEVAL G., Aktan Z., AYLI M., Palabiyikoglu R.

Transfusion and Apheresis Science , cilt.49, sa.3, ss.468-473, 2013 (SCI-Expanded, Scopus)

37. Is mean platelet volume associated with the angiographic severity of coronary artery disease?

Ekici B., Erkan A. F., Alhan A., Sayin I., AYLI M., Töre H. F.

Kardiologia Polska , cilt.71, sa.8, ss.832-838, 2013 (SCI-Expanded, Scopus)

38. The association between calcium dobesilate and pancytopenia in type 2 diabetes: A case report Tip 2 diyabet hastasında kalsiyum dobesilat ile pansitopeni ilisamp;cedil;kisi: Bir olgu sunumu

Cesur A., AYLI M., Cesur M., Ertek S.

Turkish Journal of Hematology , cilt.28, sa.1, ss.77-78, 2011 (SCI-Expanded, Scopus, TRDizin)

39. Serious venous thromboembolism, heterozygous factor V Leiden and prothrombin G20210A mutations in a patient with Klinefelter syndrome and type 2 diabetes

AYLI M., Ertek S.

Internal Medicine , cilt.48, sa.18, ss.1681-1685, 2009 (SCI-Expanded, Scopus)

40. An interesting case of pachydermoperiostosis with idiopathic myelofibrosis associated with monosomy 22

Arikan Ş., Sen I., Bahceci M., Tuzcu A., AYLI M.

International Journal of Dermatology , cilt.48, sa.8, ss.882-885, 2009 (SCI-Expanded, Scopus)

41. The effect of regimes of harvesting autologous peripheric stem cell on the number of CD34(+) cell: Experience at a single center Otolog periferik kök hücre toplama rejimlerinin CD34(+) hücre sayisi üzerine etkisi: Tek merkez deneyimi

Şahin Balçik Ö., DAĞDAŞ S., Keser Güler S., Özet G., Oymak A., Çelik Z., et al.

Turkiye Klinikleri Journal of Medical Sciences , cilt.28, sa.5, ss.640-647, 2008 (Scopus)

42. Coronary bypass surgery in essential thrombocytemia

Yörükoǧlu Y., AYLI M., Akgül E.

Anadolu Kardiyoloji Dergisi , cilt.7, sa.4, ss.444-445, 2007 (Scopus, TRDizin)

43. The autologous hematopoietic stem cell transplantation in adult patients with lymphoma: Turkish Bone Marrow Transplantation Registry results

Arpaci F., Ataergin S., GÜRMAN G., Çaǧirgan S., Arat M., Özet A., et al.

Turkish Journal of Cancer , cilt.37, sa.2, ss.45-53, 2007 (Scopus)

44. Unusual extramedullar hematopoiesis in a patient receiving granulocyte colony-stimulating factor

DAĞDAŞ S., Ozet G., Alanoglu G., AYLI M., Akoz A. G., Erekul S.

Acta Haematologica , cilt.116, sa.3, ss.198-202, 2006 (SCI-Expanded, Scopus)

45. The effect of high-flux hemodialysis on dialysis-associated amyloidosis

AYLI M., AYLI M. D., Azak A., Yüksel C., Atilgan G., DEDE F., et al.

Renal Failure , cilt.27, sa.1, ss.31-34, 2005 (SCI-Expanded, Scopus)

46. Membranous nephropathy associated with acute myeloid leukemia

Şahiner S., AYLI M., Yüksel C., Öneç K., Abayli E.

Transplantation Proceedings , cilt.36, sa.9, ss.2618-2619, 2004 (SCI-Expanded, Scopus)

47. High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation in patients with lymphoma - A retrospective evaluation

DEMİRER T., AYLI M., Fen T., ÖZCAN M. E., Arat M., Buyukberber S., et al.

Bone Marrow Transplantation , cilt.34, sa.9, ss.781-786, 2004 (Scopus)

48. The effect of high-flux hemodialysis on renal anemia

AYLI M. D., AYLI M., Azak A., Yüksel C., Koşmaz G. P., Atilgan G., et al.

Journal of Nephrology , cilt.17, sa.5, ss.701-706, 2004 (SCI-Expanded, Scopus)

49. Bacterial pyomyositis in a patient with adult acute lymphoblastic leukaemia

Aki Z., DAĞDAŞ S., Akoz A. G., Erdem Z. E., Yilmaz M., Guler N., et al.

HAEMA , cilt.7, sa.3, ss.374-377, 2004 (Scopus)

50. High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous stem cell transplantation in patients with advanced breast cancer: A retrospective evaluation

DEMİRER T., Uysal V., AYLI M., Genc Y., İLHAN ., KOÇ H., et al.

Bone Marrow Transplantation , cilt.31, sa.9, ss.755-761, 2003 (Scopus)

51. Lamivudine therapy in acute leukemia patients who are hepatitis B surface antigen carriers

Yilmaz M., DAĞDAŞ S., Güler N., Aki S. Z., Aköz A. G., Özet G., et al.

Hematology , cilt.8, sa.6, ss.393-396, 2003 (Scopus)

52. The effect of post-transplant spironolactone on daily potassium requirements in patients undergoing autologous stem cell transplantation [1]

DEMİRER T., AYLI M., Dagli M., Fen T., Haznedar R., Ustael N., et al.

Bone Marrow Transplantation , cilt.30, sa.10, ss.703-706, 2002 (Scopus)

53. Monitoring of peripheral blood CD34+ cell counts on the first day of apheresis is highly predictive for efficient CD34+ cell yield

DEMİRER T., İLHAN ., AYLI M., Arat M., Dagli M., ÖZCAN M., et al.

Therapeutic Apheresis , cilt.6, sa.5, ss.384-389, 2002 (Scopus)

54. Influence of post-transplant recombinant human granulocyte colony-stimulating factor administration on peritransplant morbidity in patients undergoing autologous stem cell transplantation

DEMİRER T., AYLI M., Dagli M., Haznedar R., YAVUZ Y., Fen T., et al.

British Journal of Haematology , cilt.118, sa.4, ss.1104-1111, 2002 (SCI-Expanded, Scopus)

55. Plasmacytoma in the bilateral breast

Daǧli M., DEMİRER T., AYLI M., Haznedar R., Günel N., Sucak G., et al.

Turkish Journal of Haematology , cilt.19, sa.4, ss.481-483, 2002 (Scopus, TRDizin)

56. Mobilization of peripheral blood stem cells with chemotherapy and recombinant human granulocyte colony-stimulating factor (rhG-CSF): A randomized evaluation of different doses of rhG-CSF

Ozet G., Dincer S., AYLI M.

British Journal of Haematology , cilt.116, sa.2, ss.468-474, 2002 (SCI-Expanded, Scopus)

57. A randomized trial of assessment of efficacy of leukapheresis volumes, 8 liters vs 12 liters

DEMİRER T., Dagli M., İLHAN ., AYLI M., Haznedar R., Fen T., et al.

Bone Marrow Transplantation , cilt.29, sa.11, ss.893-897, 2002 (SCI-Expanded, Scopus)

58. Effect of oral levamisole supplementation to hepatitis B vaccination on the rate of immune response in chronic hemodialysis patients

AYLI M., Ayli M. D., Ensari C., Mandiroǧlu F., Mut S.

Nephron , cilt.84, sa.3, ss.291-292, 2000 (SCI-Expanded, Scopus)

59. Effect of low-protein diet supplemented with keto acids on progression of disease in patients with chronic renal failure

Deniz Ayli M., AYLI M., Ensari C., Mandiroǧlu F., Allioǧlu M.

Nephron , cilt.84, sa.3, ss.288-289, 2000 (SCI-Expanded, Scopus)

60. Isolated acquired FX deficiency: A case report

AYLI M., DAĞDAŞ S., Yilmaz S.

Turkish Journal of Haematology , cilt.17, sa.1, ss.29-32, 2000 (Scopus, TRDizin)

61. Serum levels of soluble interleukin-2 receptor in patients with primary nephrotic syndrome [1]

Duman N., DURANAY M., ATEŞ K., AYLI M., Ayli M., Karatan O., et al.

Nephron , cilt.80, sa.3, ss.349-350, 1998 (SCI-Expanded, Scopus)

Yayınlar & Eserler

Yayın

Yayın (WoS)

Yayın (Scopus)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Atıf (TrDizin)

H-İndeks (TrDizin)

Atıf (Diğer Toplam)

Tez Danışmanlığı

Açık Erişim